Riskpilot← Back to searchSign inGet full accessJS Medtech AB
ABActiveOrg 5593804791Linnévägen 11Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20220 employees
Revenue 2024
SEK 49K
+44% vs 2023
EBITDA margin
-110.8%
+67% vs 2023
Equity ratio
4.2%
Financial strength
Net profit 2024
SEK 531
+199% vs 2023
| Revenue | SEK 49K | +44% |
| EBITDA | SEK -54K | +67% |
| Net profit | SEK 531 | +199% |
| Total assets | SEK 667K | -23% |
| Equity | SEK 28K | +2% |
| Employees | 0 | — |
Legal name
JS Medtech AB
Org number
5593804791
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
12 maj 2022
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva import, export, utveckling, marknadsföring samt försäljning av handikapphjälpmedel, tillhandahålla ekonomiska och juridiska konsulttjänster, mekanisk konsultverksamhet, maskinbyggnation inom handikapphjälpmedel och därmed förenlig verksamhet.
Address
Linnévägen 11
Email
johsva@me.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 53 | 34 | 49 |
| Staff expenses | — | — | — |
| EBITDA | −3 | −163 | −54 |
| Depreciation & amort. | −104 | −178 | −178 |
| EBIT | −107 | −342 | −232 |
| Net financials | −0 | −4 | −4 |
| Profit before tax | −107 | −1 | 1 |
| Tax | — | — | — |
| Net profit | −107 | −1 | 1 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 1 078 | 872 | 667 |
| Equity | 28 | 28 | 28 |
| Long-term debt | 1 050 | 842 | 633 |
| Short-term debt | — | 2 | 6 |
| Total debt | 1 050 | 844 | 639 |
EBITDA margin
-110.8%
This company
15.8%
Market median
-801% vs market
20222024
Equity ratio
4.2%
This company
38.2%
Market median
-89% vs market
20222024
Return on equity
1.9%
This company
18.4%
Market median
-90% vs market
20222024
Net profit margin
1.1%
This company
8.1%
Market median
-86% vs market
20222024
Asset turnover
0.07×
This company
1.12×
Market median
-94% vs market
20222024
Debt / equity
22.62×
This company
0.62×
Market median
-3548% vs market
20222024
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LG Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2024 | |
| Former (3) | ||
| Deputy Board Member | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2024 | |
| Board of Directors | 2022 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Johan Svahn Invest AB
JS Medtech AB Board members of JS Medtech AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Gustav Johan Svahn | Chief Executive Officer | 0 companies |
| Eva Margareta Eljans | Deputy Board Member | 0 companies |
| Ingrid Mariana Svahn | Deputy Board Member | 0 companies |
| Dan Erik Göran Norman | Deputy Board Member | 0 companies |
| Anita Helena Berggren | Board of Directors | 0 companies |